ong-term neurocognitive assessment of children following an episode of severe malaria: the artesunate suppository trial cohort

Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)0 个研究点目标入组 6,000 人开始时间: 2013年5月28日最近更新: 2019年2月11日

试验速览

暂无简介。

•TQQ+ questionnaire, socioeconomic status, clinical history, height on:
•1. Surviving children originally enrolled in Study 13
•2. Male or female
•3. Written informed consent by legally acceptable representative (plus assent if appropriate)
•4. Willingness and ability of the participants/guardians to comply with the study tests
•Detailed neurocognitive exams
•1. ~30% stratified sample of the surviving study cohort meeting criteria above
•2. TQQ positive children
•3. >8 years of age
•(Additional inclusion criteria will apply for participants who undergo EEG and/or MRI)

•1. Signs of acute illness
•Detailed neurocognitive exams
•1. Signs of acute illness
•2. Anti-malarial injection at enrolment into Study 13
•(Additional exclusion criteria will apply for participants who will undergo EEG and/or MRI)

发起方

Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)